Abstract | STUDY OBJECTIVE: To (1) replicate our prior result of low cerebrospinal fluid (CSF) histamine levels in human narcolepsy in a different sample population and to (2) evaluate if histamine contents are altered in other types of hypersomnia with and without hypocretin deficiency. DESIGN: Cross sectional studies. SETTING AND PATIENTS: RESULTS: CONCLUSION:
|
Authors | Takashi Kanbayashi, Tohru Kodama, Hideaki Kondo, Shinsuke Satoh, Yuichi Inoue, Shigeru Chiba, Tetsuo Shimizu, Seiji Nishino |
Journal | Sleep
(Sleep)
Vol. 32
Issue 2
Pg. 181-7
(Feb 2009)
ISSN: 0161-8105 [Print] United States |
PMID | 19238805
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antidepressive Agents
- Central Nervous System Stimulants
- Intracellular Signaling Peptides and Proteins
- Neuropeptides
- Orexins
- Histamine
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Antidepressive Agents
(therapeutic use)
- Cataplexy
(cerebrospinal fluid, diagnosis, drug therapy)
- Central Nervous System Stimulants
(therapeutic use)
- Cross-Sectional Studies
- Disorders of Excessive Somnolence
(cerebrospinal fluid, diagnosis, drug therapy)
- Female
- Histamine
(cerebrospinal fluid, deficiency)
- Humans
- Intracellular Signaling Peptides and Proteins
(cerebrospinal fluid, deficiency)
- Male
- Middle Aged
- Narcolepsy
(cerebrospinal fluid, diagnosis, drug therapy)
- Nervous System Diseases
(cerebrospinal fluid, diagnosis)
- Neuropeptides
(cerebrospinal fluid, deficiency)
- Orexins
- Reference Values
- Sleep Apnea, Obstructive
(cerebrospinal fluid, diagnosis, drug therapy)
- Young Adult
|